Three-dimensional glass-derived scaffolds for bone tissue engineering: Current trends and forecasts for the future

Journal of Biomedical Materials Research - Part A

Volumn 97 A, Issue 4, 2011, Pages 514-535

  Baino, Francesco ^a   Vitale Brovarone, Chiara ^a  

^a POLITECNICO DI TORINO   (Italy)

Author keywords

bioactivity; bone regeneration; hierarchical systems; hybrid; porosity

Indexed keywords

BONE CELLS; BONE REGENERATION; BONE TISSUE ENGINEERING; CURRENT TRENDS; DRUG RELEASE; FUTURE DIRECTIONS; HYBRID; MACROPOROUS GLASS; MULTIFUNCTIONAL SYSTEMS; NATURAL TISSUES; NON DESTRUCTIVE; OSTEOGENESIS; POROUS TEMPLATES; REGENERATIVE MEDICINE; SOL-GEL GLASS; X RAY MICROTOMOGRAPHY;

BIOLOGICAL MATERIALS; BONE; GLASS; HIERARCHICAL SYSTEMS; IMAGING TECHNIQUES; STEM CELLS; THREE DIMENSIONAL;

SCAFFOLDS (BIOLOGY);

BORIC ACID; GLASS; NANOCOMPOSITE; PHOSPHATE; POLYMER; SILICATE; TISSUE SCAFFOLD;

BONE CELL; BONE DEVELOPMENT; BONE REGENERATION; BONE TISSUE; CERAMICS; COMPOSITE MATERIAL; DRUG RELEASE; MATERIAL COATING; MICRO-COMPUTED TOMOGRAPHY; POROSITY; REVIEW; TISSUE ENGINEERING;

ANIMALS; BONE AND BONES; CERAMICS; GLASS; HUMANS; POROSITY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79955665338     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33072     Document Type: Review

References (177)

1. Schlickewei W, Schlickewei C,. The use of bone substitutes in the treatment of bone defects - The clinical view and history. Macromol Symp 2007; 253: 10-23. (Pubitemid 47265419)
2. Hutmacher DW,. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000; 21: 2529-2543.
3. Karageorgiou V, Kaplan D,. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005; 26: 5474-5491. (Pubitemid 40592136)
4. Hench LL,. Biomaterials: a forecast for the future. Biomaterials 1998; 19: 1419-1423. (Pubitemid 28470667)
5. Hench LL, Splinter RJ, Allen WC, Greenlee TK,. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res 1972; 2: 117-141.
6. Rouquerol J, Avnir D, Fairbridge CW, Everett DH, Haynes JM, Pernicone N, Ramsay JDF, Sing KSW, Unger KK,. Recommendations for the characterization of porous solids. Pure Appl Chem 1994; 66: 1739-1758.
7. Chevalier J, Gremillard L,. Ceramics for medical applications: A picture for the next 20 years. J Eur Ceram Soc 2009; 29: 1245-1255.
8. Hench LL, Wilson J,. Introduction to Bioceramics. Singapore: World Scientific; 1993.
9. 2. J Biomed Mater Res 1997; 37: 114-121. (Pubitemid 27427571)
10. Huang W, Day DE, Kittiratanapiboon K, Rahaman MN,. Kinetics and mechanism of the conversion of silicate (45S5), borate and borosilicate glasses to hydroxyapatite in dilute phosphate solutions. J Mater Sci Mater Med 2006; 17: 583-596. (Pubitemid 43886421)
11. 2O phosphate glass-ceramic for tissue engineering applications. Acta Biomater 2010; 6: 598-606.
12. Oki A, Parveen B, Hossain S, Adeniji S, Donahue H,. Preparation and in vitro bioactivity of zinc containing sol-gel-derived bioglass materials. J Biomed Mater Res A 2004; 69: 216-221. (Pubitemid 38478814)
13. Balamurugan A, Balossier G, Kannan S, Michel J, Rebelo AH, Ferreira JM,. Development and in vitro characterization of sol-gel derived CaO-P2O5-SiO2-ZnO bioglass. Acta Biomater 2007; 3: 255-262. (Pubitemid 46223894)
14. Saboori A, Sheikhi M, Moztarzadeh F, Rabiee M, Hesaraki S, Tahriri M,. Sol-gel preparation, characterisation and in vitro bioactivity of Mg containing bioactive glass. Adv Appl Ceram 2009; 108: 155-161.
15. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ,. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 1996; 18: 517-523. (Pubitemid 26257871)
16. 2+ on the structure and reactivity of SrO-CaO-ZnO-SiO2 ionomer glasses. J Mater Sci: Mater Med 2008; 19: 953-957. (Pubitemid 351236749)
17. Hesaraki S, Alizadeh M, Nazarian H, Sharifi D,. Physico-chemical and in vitro biological evaluation of strontium/calcium silico-phosphate glass. J Mater Sci Mater Med 2010; 21: 695-705.
18. Gentleman E, Fredholm YC, Jell G, Lotfibakhshaiesh N, O'Donnell MD, Hill RG, Stevens MM,. The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro. Biomaterials 2010; 31: 3949-3956.
19. O'Donnell MD, Hill RG,. Influence of strontium and the importance of glass chemistry and structure when designing bioactive glasses for bone regeneration. Acta Biomater 2010; 6: 2382-2385.
20. Li L, Clark AE, Hench LL,. An investigation of bioactive glass powders by sol-gel processing. J Appl Biomater 1991; 2: 231-239.
21. Sepulveda P, Jones JR, Hench LL,. In vitro dissolution of melt-derived 45S5 and sol-gel derived 58S bioactive glasses. J Biomed Mater Res 2002; 61: 301-311. (Pubitemid 34602378)
22. Peitl FO, LaTorre GP, Hench LL,. Effect of crystallization on apatite-layer formation of bioactive glass 45S5. J Biomed Mater Res 1996; 30: 509-514. (Pubitemid 26107084)
23. Clupper DC, Mecholsky JJ, Jr., LaTorre GP, Greenspan DC,. Bioactivity of tape cast and sintered glass-ceramic in simulated body fluid. Biomaterials 2002; 23: 2599-2606. (Pubitemid 34288499)
24. Lefebvre L, Gremillard L, Chevalier J, Zenati R, Bernache-Assolat D,. Sintering behaviour of 45S5 bioactive glass. Acta Biomater 2008; 4: 1894-1903.
25. Huang R, Pan J, Boccaccini AR, Chen QZ,. A two-scale model for simultaneous sintering and crystallization of glass-ceramic scaffolds for tissue engineering. Acta Biomater 2008; 4: 1095-1103.
26. Xynos ID, Hukkanen MV, Batten JJ, Buttery LD, Hench LL, Polak JM,. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int 2000; 67: 321-329.
27. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM,. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res 2001; 55: 151-157. (Pubitemid 32198497)
28. Hench LL, Xynos ID, Polak JM,. Bioactive glasses for in situ tissue regeneration. J Biomater Sci Polym Ed 2004; 15: 543-562. (Pubitemid 38607322)
29. Hench LL,. Genetic design of bioactive glasses. J Eur Ceram Soc 2008; 29: 1257-1265.
30. A. J Mater Sci Mater Med 2006; 17: 967-978.
31. Sepulveda P, Jones JR, Hench LL,. Bioactive sol-gel foams for tissue repair. J Biomed Mater Res A 2002; 49: 340-348.
32. Pereira MM, Clark AE, Hench LL,. Effect of texture on the rate of hydroxyapatite formation on gel silica surface. J Am Ceram Soc 1995; 78: 2463-2468.
33. Fitzgerald V, Martin RA, Jones JR, Qiu D, Wetherall KM, Moss RM, Newport RJ,. Bioactive glass sol-gel foam scaffolds: Evolution of nanoporosity during processing and in situ monitoring of apatite layer formation using small- and wide-angle X-ray scattering. J Biomed Mater Res A 2009; 91: 76-83.
34. Jones JR, Hench LL,. Effect of surfactant concentration and composition on the structure and properties of sol-gel-derived bioactive glass scaffolds for tissue engineering. J Mater Sci 2003; 38: 1-8.
35. Jones JR, Hench LL,. The effect of processing variables on the properties of bioactive glass foams. J Biomed Mater Res B 2004; 68: 36-44.
36. Jones JR, Ehrenfried LM, Hench LL,. Optimising bioactive glass scaffolds for bone tissue engineering. Biomaterials 2006; 27: 964-973. (Pubitemid 41566688)
37. Thompson JD, Hench LL,. Mechanical properties of bioactive glasses, glass-ceramics and composites. Proc Inst Mech Eng H J Eng Med 1998; 212: 127-136.
38. Jones JR, Poologasundarampillai G, Atwood RC, Bernard D, Lee PD,. Non-destructive quantitative 3D analysis for the optimisation of tissue scaffolds. Biomaterials 2007; 28: 1404-1413. (Pubitemid 44959043)
39. Rainer A, Giannitelli S, Abbruzzese F, Licoccia S, Traversa E, Trombetta M,. Fabrication of bioactive glass-ceramic foams mimicking human bone portions for regenerative medicine. Acta Biomater 2008; 4: 362-369. (Pubitemid 351227247)
40. A-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials 2006; 27: 2414-2425. (Pubitemid 41821820)
41. Tamai N, Myoui A, Tomita T, Nakase T, Tanaka J, Ochi T,. Novel hydroxyapatite ceramics with an interconnective porous structure inhibit superior osteoconduction in vivo. J Biomed Mater Res 2002; 59: 110-117.
42. A-derived glass-ceramic scaffolds by using rice husk as a porogen additive. J Mater Sci Mater Med 2009; 20: 1229-1236.
43. Bellucci D, Cannillo V, Sola A,. Shell scaffolds: a new approach towards high strength bioceramic scaffolds for bone regeneration. Mater Lett 2010; 64: 203-206.
44. Cannillo V, Sola A,. Potassium-based compositions for a bioactive glass. Ceram Int 2009; 35: 3389-3393.
45. Bellucci D, Cannillo V, Ciardelli G, Gentile P, Sola A,. Potassium based bioactive glass for bone tissue engineering. Ceram Int 2010; 36: 2449-2453.
46. Vitale-Brovarone C, Miola M, Balagna C, Verné E,. 3D-glass-ceramic scaffolds with antibacterial properties for bone grafting. Chem Eng J 2008; 137: 129-136. (Pubitemid 351226630)
47. Vitale-Brovarone C, Verné E, Robiglio L, Appendino P, Bassi F, Martinasso G, Muzio G, Canuto R,. Development of glass-ceramic scaffolds for bone tissue engineering: Characterisation, proliferation of human osteoblasts and nodule formation. Acta Biomater 2007; 3: 199-208. (Pubitemid 46223892)
48. Muzio G, Verné E, Canuto RA, Martinasso G, Saracino S, Baino F, Mola M, Berta L, Frairia R, Vitale-Brovarone C,. Shock waves induce activity of human osteoblast-like cells in bioactive scaffolds. J Trauma Inj Infect Crit Care 2010; 68: 1439-1444.
49. Vitale-Brovarone C, Baino F, Verné E,. High strength bioactive glass-ceramic scaffolds for bone regeneration. J Mater Sci Mater Med 2009; 20: 643-653.
50. Baino F, Verné E, Vitale-Brovarone C,. 3-D high strength glass-ceramic scaffolds containing fluoroapatite for load-bearing bone portions replacement. Mater Sci Eng C 2009; 29: 2055-2062.
51. Vitale-Brovarone C, Verné E, Robiglio L, Martinasso G, Canuto RA, Muzio G,. Biocompatible glass-ceramic materials for bone substitution. J Mater Sci Mater Med 2008; 19: 471-478.
52. Vitale-Brovarone C, Di Nunzio S, Bretcanu O, Verné E,. Macroporous glass-ceramic materials with bioactive properties. J Mater Sci Mater Med 2004; 15: 209-217. (Pubitemid 38388818)
53. 2O-CaO-MgO glass-ceramic bioactive scaffolds for bone substitutes. J Mater Sci Mater Med 2005; 16: 909-917. (Pubitemid 41355618)
54. Vitale-Brovarone C, Verné E, Appendino P,. Macroporous bioactive glass-ceramic scaffolds for tissue engineering. J Mater Sci Mater Med 2006; 17: 1069-1078. (Pubitemid 44835994)
55. Fu Q, Rahaman MN, Bal BS, Brown RF, Day DE,. Mechanical and in vitro performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique. Acta Biomater 2008; 4: 1854-1864.
56. Brink M,. The influence of alkali and alkali earths on the working range for bioactive glasses. J Biomed Mater Res 1997; 36: 109-117. (Pubitemid 27271004)
57. Liang W, Rahaman MN, Day DE, Marion NW, Riley GC, Mao JJ,. Bioactive borate glass scaffold for bone tissue engineering. J Non-Cryst Solids 2008; 354: 1690-1696. (Pubitemid 351248864)
58. Rahaman MN, Liang W, Day DE, Marion NW, Reilly GC, Mao JJ,. Preparation and bioactive characteristics of porous borate glass substrates. Ceram Eng Sci Proc 2005; 26: 3-10. (Pubitemid 43195753)
59. Marion NW, Liang W, Liang W, Reilly GC, Day DE, Rahaman MN, Mao JJ,. Borate glass supports the in vitro osteogenic differentiation of human mesenchymal stem cells. Mech Adv Mater Struct 2005; 12: 239-246. (Pubitemid 41673169)
60. Fu H, Fu Q, Zhou N, Huang W, Rahaman MN, Wang D, Liu X,. In vitro evaluation of borate-based bioactive glass scaffolds prepared by a polymer foam replication method. Mater Sci Eng C 2009; 29: 2275-2281.
61. Ning J, Yao A, Wang D, Huang W, Fu H, Liu X, Jiang X, Zhang X,. Synthesis and in vitro bioactivity of a borate-based bioglass. Mater Lett 2007; 61: 5223-5226. (Pubitemid 47632831)
62. Liu X, Huang W, Fu H, Yao A, Wang D, Pan H, Lu WW,. Bioactive borosilicate glass scaffolds: improvement on the strength of glass-based scaffolds for tissue engineering. J Mater Sci Mater Med 2009; 20: 375-362.
63. Liu X, Pan H, Fu H, Fu Q, Rahaman MN, Huang W., Conversion of borate-based glass scaffold to hydroxyapatite in a dilute phosphate solution. Biomed Mater 2010; 5: 15005.
64. Liu X, Huang W, Fu H, Yao A, Wang D, Pan H, Lu WW, Jiang X, Zhang X,. Bioactive borosilicate glass scaffolds: In vitro degradation and bioactivity behaviours. J Mater Sci Mater Med 2009; 20: 1237-1243.
65. Bunker BC, Arnold GW, Wilder JA,. Phosphate glass dissolution in aqueous solutions. J Non-Cryst Solids 1984; 64: 291-316. (Pubitemid 14605679)
66. Gao H, Tan T, Wang D,. Dissolution mechanism and release kinetics of phosphate controlled release glasses in aqueous medium. J Control Rel 2004; 96: 29-36. (Pubitemid 38438487)
67. Abou Neel EA, Mizoguchi T, Ito M, Bitar M, Salih V, Knowles JC,. In vitro bioactivity and gene expression by cells cultured on titanium dioxide doped phosphate-based glasses. Biomaterials 2007; 28: 2967-2977. (Pubitemid 46560873)
68. Abou Neel EA, Knowles JC,. Physical and biocompatibility studies of novel titanium dioxide doped phosphate-based glasses for bone tissue engineering applications. J Mater Sci Mater Med 2008; 19: 377-386.
69. 2 and its effect on solubility and in vitro biocompatibility. Submitted for publication.
70. Abou Neel EA, Ahmed I, Pratten J, Nazhat SN, Knowles JC,. Characterisation of antibacterial copper releasing degradable phosphate glass fibres. Biomaterials 2005; 26: 2247-2254. (Pubitemid 39600678)
71. Ahmed I, Collins CA, Lewis MP, Olsen I, Knowles JC,. Processing, characterisation and biocompatibility of iron-phosphate glass fibres for tissue engineering. Biomaterials 2004; 25: 3223-3232. (Pubitemid 38234783)
72. Abou Neel EA, Ahmed I, Blaker JJ, Bismarck A, Boccaccini AR, Lewis MP, Nazhat SN, Knowles JC,. Effect of iron on the surface, degradation and ion release properties of phosphate-based glass fibres. Acta Biomater 2005; 1: 553-563. (Pubitemid 43348770)
73. Valappil SP, Pickup DM, Carroll DL, Hope CK, Pratten J, Newport RJ, Smith ME, Wilson M, Knowles JC,. Effect of silver content on the structure and antibacterial activity of silver-doped phosphate-based glasses. Antimicrob Agents Chemother 2007; 51: 4453-4461. (Pubitemid 350209902)
74. Gilchrist T, Glasby MA, Healy DM, Kelly G, Lenihan DV, McDowall KL, Miller IA,. In vitro nerve repair-in vivo. The reconstruction of peripheral nerves by entubulation with biodegradable glass tubes - A preliminary report. Br J Plast Surg 1998; 51: 231-237. (Pubitemid 28200960)
75. Jeans LA, Gilchrist T, Healy D,. Peripheral nerve repair by means of flexible biodegradable glass fibre wrap: A comparison with microsurgical epineuril repair. J Plast Reconstr Aesthet Surg 2007; 60: 1302-1308. (Pubitemid 350082083)
76. Shah R, Sinanan ACM, Knowles JC, Hunt NP, Lewis MP,. Craniofacial muscle engineering using a 3-dimensional phosphate glass fibre construct. Biomaterials 2005; 26: 1497-1505. (Pubitemid 39441382)
77. Sanzana ES, Navarro M, Macule F, Suso S, Planell JA, Ginebra MP,. Of the in vivo behavior of calcium phosphate cements and glasses as bone substitutes. Acta Biomater 2008; 4: 1924-1933.
78. Abou Neel EA, Chrzanowski W, Pickup DM, O'Dell LA, Mordan NJ, Newport RJ, Smith ME, Knowles JC,. Structure and properties of strontium-doped phosphate-based glasses. J R Soc Interf 2009; 6: 435-446.
79. Navarro M, Del Valle S, Martínez S, Zeppetelli S, Ambrosio L, Planell JA, Ginebra MP,. New macroporous calcium phosphate glass ceramic for guided bone regeneration. Biomaterials 2004; 25: 4233-4241. (Pubitemid 38388584)
80. Vitale-Brovarone C, Verné E, Baino F, Ciapetti G, Leonardi E, Baldini N,. Bioresorbable phosphate scaffolds for bone regeneration. Key Eng Mater 2008; 361/363: 241-244.
81. Vitale-Brovarone C, Baino F, Bretcanu O, Verné E,. Foam-like scaffolds for bone tissue engineering based on a novel couple of silicate-phosphate specular glasses: Synthesis and properties. J Mater Sci Mater Med 2009; 20: 2197-2205.
82. Vitale-Brovarone C, Ciapetti G, Leonardi E, Baldini N, Bretcanu O, Verné E, Baino F,. Resorbable glass-ceramic phosphate-based scaffolds for bone tissue engineering: Synthesis, properties and in vitro effects on human marrow stromal cells. J Biomater Appl. doi: 10.1177/0885328210372149.
83. Cai S, Xu GH, Yu XZ, Zhang WJ, Xiao ZY, Yao KD,. Fabrication and biological characteristics of β-tricalcium phosphate porous ceramic scaffolds reinforced with calcium phosphate glass. J Mater Sci Mater Med 2009; 20: 351-358.
84. Devin JE, Attawia MA, Laurencin CT,. Three-dimensional degradable porous polymer-ceramic matrices for use in bone repair. J Biomater Sci Polym Ed 1996; 7: 661-669. (Pubitemid 26171647)
85. Zhang RY, Ma PX,. Poly(α-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 1999; 44: 446-455. (Pubitemid 29031128)
86. Ambrosio AMA, Sahota JS, Khan Y, Laurencin CT,. A novel amorphous calcium phosphate polymer ceramic for bone repair: I. Synthesis and characterization. J Biomed Mater Res 2001; 58: 295-301. (Pubitemid 34274505)
87. Yao J, Radin S, Leboy PS, Ducheyne P,. The effect of bioactive glass content on synthesis and bioactivity of composite poly(lactic-co-glycolic acid)/bioactive glass substrate for tissue engineering. Biomaterials 2005; 26: 1935-1943. (Pubitemid 39575335)
88. Khan YM, Dhirendra DS, Katti S, Laurencin CT,. Novel polymer-synthesized ceramic composite-based system for bone repair: an in vitro evaluation. J Biomed Mater Res A 2004; 69: 728-737. (Pubitemid 38745719)
89. A-filled polylactide foams. J Biomed Mater Res A 2003; 66: 335-346. (Pubitemid 37517234)
90. A composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation. Biomaterials 2004; 25: 4185-4194. (Pubitemid 38396765)
91. A for tissue engineering applications. Biomaterials 2002; 23: 3871-3878. (Pubitemid 34830405)
92. Stamboulis AG, Boccaccini AR, Hench LL,. Novel biodegradable polymer/bioactive glass composites for tissue engineering applications. Adv Eng Mater 2002; 4: 105-109.
93. Lu HH, Saadiq F, El-Amin SF, Scott KD, Laurencin CT,. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro. J Biomed Mater Res A 2003; 64: 465-474. (Pubitemid 37522486)
94. A-filled polylactide foams for bone tissue engineering scaffolds. J Biomed Mater Res A 2003; 67: 1401-1411. (Pubitemid 37522755)
95. Zhang K, Wang Y, Hillmayer MA, Francis LF,. Processing and properties of porous poly(L-lactide)/bioactive glass composites. Biomaterials 2004; 25: 2489-2500. (Pubitemid 38147439)
96. A composites for soft-tissue and hard-tissue engineering: An in vitro cell biology assessment. Biomaterials 2004; 25: 3013-3021. (Pubitemid 38213148)
97. Blaker JJ, Maquet V, Jerome R, Boccaccini AR, Nazhat SN,. Mechanically anisotropic PDLLA/Bioglass composite foams as scaffolds for bone tissue engineering. Acta Biomater 2005; 1: 643-652. (Pubitemid 43348757)
98. A composite tubular foam scaffolds for tissue engineering applications. Mater Sci Eng C 2005; 25: 23-31.
99. Bretcanu O, Chen Q, Misra SK, Boccaccini AR, Verné E, Vitale-Brovarone C,. Biodegradable polymer coated 45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering. Glass Tech Eur J Glass Sci Tech A 2007; 48: 227-234. (Pubitemid 350253960)
100. Misra SK, Ansari TI, Valappil SP, Mohn D, Philip SE, Stark WJ, Roy I, Knowles JC, Salih V, Boccaccini AR,. Poly(3-hydroxybutyrate) multifunctional composite scaffolds for tissue engineering applications. Biomaterials 2010; 31: 2806-2815.
101. A composites with tailored pore structure for tissue engineering applications. Compos Sci Technol 2003; 63: 2417-2429. (Pubitemid 37365665)
102. Baino F, Verné E, Vitale-Brovarone C,. Feasibility, tailoring and properties of polyurethane/bioactive glass composite scaffolds for tissue engineering. J Mater Sci Mater Med 2009; 20: 2189-2195.
103. Mantsos T, Chatzistavrou X, Roether JA, Hupa L, Arstila H, Boccaccini AR, Non-crystalline composite tissue engineering scaffolds using boron-containing bioactive glass and poly(D,L-lactic acid) coatings. Biomed Mater 2009; 4: 055002.
104. Navarro M, Ginebra MP, Planell JA, Zeppetelli S, Ambrosio L,. Development and cell response of a new biodegradable composite scaffold for guided bone regeneration. J Mater Sci Mater Med 2004; 15: 419-422. (Pubitemid 39012155)
105. Navarro M, Aparicio C, Charles-Harris M, Ginebra MP, Engel E, Planell JA,. Development of a biodegradable composite scaffold for bone tissue engineering: physicochemical, topographical, mechanical, degradation, and biological properties. Adv Polym Sci 2006; 200: 209-231.
106. Gentile P, Chiono V, Boccafoschi F, Baino F, Vitale-Brovarone C, Verné E, Barbani N, Ciardelli G,. Composite films of gelatin and hydroxyapatite/bioactive glass for tissue-engineering applications. J Biomater Sci Polym Ed 2010; 21: 1207-1226.
107. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR,. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006; 27: 3413-3431.
108. Mohamad Yunos D, Bretcanu O, Boccaccini AR, Polymer-bioceramic composites for tissue engineering scaffolds. J Mater Sci 2008; 43: 4433-4442.
109. Xiong Z, Yan YN, Wang S, Zhang R, Zhang C,. Fabrication of porous scaffolds for bone tissue engineering via low-temperature deposition. Scripta Mater 2002; 46: 771-776. (Pubitemid 34524227)
110. Taboas JM, Maddox RD, Krebsbach PH, Hollister SJ,. Indirect solid free form fabrication of local and global porous, biomimetic and composite 3D polymer-ceramic scaffolds. Biomaterials 2003; 24: 181-194. (Pubitemid 35303368)
111. Hollister SJ,. Porous scaffold design for tissue engineering. Nat Mater 2005; 4: 518-524. (Pubitemid 40952745)
112. Misra SK, Ansari T, Mohn D, Valappil SP, Brunner TJ, Stark WJ, Roy I, Knowles JC, Sibbons PD, Jones EV, Boccaccini AR, Salih V,. Effect of nanoparticulate bioactive glass particles on bioactivity and cytocompatibility of poly(3-hydroxybutyrate) composites. J R Soc Interf 2010; 7: 453-465.
113. Jones JR,. New trends in bioactive scaffolds: the importance of nanostructure. J Eur Ceram Soc 2009; 29: 1275-1281.
114. Pereira MM, Jones JR, Orefice RL, Hench LL,. Preparation of bioactive glass-polyvinyl alcohol hybrid foams by the sol-gel method. J Mater Sci Mater Med 2005; 16: 1045-1050. (Pubitemid 43039922)
115. Pereira MM, Jones JR, Hench LL,. Bioactive glass and hybrid scaffolds prepared by sol-gel method for bone tissue engineering. Adv Appl Ceram 2005; 104: 35-42. (Pubitemid 41066364)
116. Arcos D, Vallet-Regi M,. Sol-gel silica based biomaterials and bone tissue regeneration. Acta Biomater 2010; 6: 2874-2888.
117. Tian D, Blacher S, Pirard JP, Jerome R,. Biodegradable and biocompatible inorganic-organic hybrid materials. III. A valuable route to the control of the silica porosity. Langmuir 1998; 14: 1905-1910. (Pubitemid 128587184)
118. Rhee SH, Lee YK, Lim BS,. Evaluation of a novel poly(epsilon- caprolactone)-organosiloxane hybrid material for the potential application as a bioactive and degradable bone substitute. Biomacromolecules 2004; 5: 1575-1579.
119. Eglin D, Ali SAM, Perry CC,. Comparative study of the in vitro apatite-forming ability of poly(epsilon-caprolactone)-silica sol-gels using three osteoconductivity tests (static, dynamic, and alternate soaking process). J Biomed Mater Res A 2004; 69: 718-727. (Pubitemid 38750176)
120. Rhee SH,. Bone-like apatite-forming ability and mechanical properties of poly(epsilon-caprolactone)/silica hybrid as a function of poly(epsilon- caprolactone) content. Biomaterials 2004; 25: 1167-1175.
121. Rhee SH, Lee SJ,. Effect of acidic degradation products of poly(lactic-co-glycolic)acid on the apatite-forming ability of poly(lactic-co-glycolic)acid-siloxane nanohybrid material. J Biomed Mater Res A 2007; 83: 799-805.
122. Zhu A, Zhang M, Shen R,. Covalent immobilization of o-butyrylchitosan with a photosensitive hetero-bifunctional crosslinking reagent on biopolymer substrate surface and blood compatibility characterization. J Biomater Sci Polym Ed 2003; 14: 411-421. (Pubitemid 36675412)
123. Ren L, Tsuru K, Hayakawa S, Osaka A,. Synthesis and characterization of gelatin-siloxane hybrids derived through sol-gel procedure. J Sol-Gel Sci Technol 2001; 21: 115-121. (Pubitemid 32512188)
124. Ren L, Tsuru K, Hayakawa S, Osaka A,. Novel approach to fabricate porous gelatin-siloxane hybrids for bone tissue engineering. Biomaterials 2002; 23: 4765-4773. (Pubitemid 35286697)
125. Ren L, Tsuru K, Hayakawa S, Osaka A,. In vitro evaluation of osteoblast response to sol-gel derived gelatin-siloxane hybrids. J Sol-Gel Sci Technol 2003; 26: 1137-1140.
126. Vallet-Regi M, Salinas AJ, Arcos D,. From the bioactive glasses to the star gels. J Mater Sci Mater Med 2006; 17: 1011-1017. (Pubitemid 44835985)
127. Manzano M, Arcos D, Delgado MR, Ruiz E, Gil FJ, Vallet-Regi M,. Bioactive star gels. Chem Mater 2006; 18: 5696-5703. (Pubitemid 44893455)
128. Boskey AL,. Mineralization of bones and teeth. Elements 2007; 6: 385-392.
129. Miao X, Sun D,. Graded/gradient porous biomaterials. Materials 2010; 3: 26-47.
130. Cauda V, Fiorilli S, Onida B, Verné E, Vitale-Brovarone C, Viterbo D, Croce G, Milanesio M, Garrone E,. SBA-15 ordered mesoporous silica inside a bioactive glass-ceramic scaffold for local drug delivery. J Mater Sci Mater Med 2008; 19: 3303-3310.
131. Mortera R, Onida B, Fiorilli S, Cauda V, Vitale-Brovarone C, Baino F, Verné E, Garrone E,. Synthesis of MCM-41 spheres inside bioactive glass-ceramic scaffold. Chem Eng J 2008; 137: 54-61. (Pubitemid 351226633)
132. Vitale-Brovarone C, Baino F, Miola M, Mortera R, Onida B, Verné E,. Glass-ceramic scaffolds containing silica mesophases for bone grafting and drug delivery. J Mater Sci Mater Med 2009; 20: 809-820.
133. Mortera R, Baino F, Croce G, Fiorilli S, Vitale-Brovarone C, Verné E, Onida B,. Monodisperse mesoporous silica spheres inside a bioactive macroporous glass-ceramic scaffold. Adv Eng Mater 2010; 12: 256-259.
134. Simske SJ, Ayers RA, Bateman TA,. Porous materials for bone engineering. Mater Sci Forum 1997; 250: 151-182. (Pubitemid 127565061)
135. A-derived glass-ceramic scaffolds exhibiting porosity gradient. J Mater Sci 2008; 43: 4127-4134.
136. Vitale-Brovarone C, Baino F, Verné E,. Feasibility and tailoring of bioactive glass-ceramic scaffolds with gradient of porosity for bone grafting. J Biomater Appl 2010; 24: 693-712.
137. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS,. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992; 359: 710-712. (Pubitemid 23589384)
138. Vallet-Regi M,. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem Eur J 2006; 12: 5934-5943. (Pubitemid 44231020)
139. Izquierdo-Barba I, Ruiz-Gonzalez L, Doadrio JC, Gonzalez-Calbet J, Vallet-Regi M,. Tissue regeneration: A new property of mesoporous materials. Solid State Sci 2005; 7: 983-989. (Pubitemid 41068445)
140. Vallet-Regi M, Izquierdo-Barba I, Ramila A, Perez-Pariente J, Babonneau F, Gonzalez-Calbet J,. Phosphorous-doped MCM-41 as bioactive material. Solid State Sci 2005; 7: 233-237. (Pubitemid 40269524)
141. Horcajada P, Ramila A, Boulahya K, Gonzalez-Calbet J, Vallet-Regi M,. Bioactivity in ordered mesoporous materials. Solid State Sci 2004; 6: 1295-1300.
142. Yan X, Yu C, Zhou X, Tang J, Zhao D,. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angew Chem Int Ed 2004; 43: 5980-5984. (Pubitemid 39551337)
143. Xia W, Chang J,. Well ordered mesoporous bioactive glasses (MBG): A promising bioactive drug delivery system. J Control Rel 2006; 110: 522-530. (Pubitemid 43163442)
144. Lopez-Noriega A, Arcos D, Izquiendo-Barba I, Sakamoto Y, Terasaki O, Vallet-Regi M,. Ordered mesoporous bioactive glasses for bone tissue regeneration. Chem Mater 2006; 18: 3137-3144. (Pubitemid 44116093)
145. Xia W, Chang J,. Preparation. in vitro bioactivity and drug release property of well ordered 58S bioactive glass. J Non-Cryst Solids 2008; 354: 1338-1341. (Pubitemid 351172322)
146. Vallet-Regi M, Ragel CV, Salinas AJ,. Glasses with application. Eur J Inorg Chem 2003; 6: 1029-1042.
147. Sepulveda P, Jones JR, Hench LL,. Characterization of melt-derived 45S5 and sol-gel-derived 58S bioactive glasses. J Biomed Mater Res 2001; 58: 734-740. (Pubitemid 33100011)
148. Mortera R, Fiorilli S, Garrone E, Onida B,. Structural changes of MCM-41 spheres during ibuprofen release to SBF. Stud Surf Sci Catal B 2008; 174: 1001-1004.
149. Mortera R, Fiorilli S, Garrone E, Verné E, Onida B,. Pores occlusion in MCM-41 spheres immersed in SBF and the effect on ibuprofen delivery kinetics: A quantitative model. Chem Eng J 2010; 156: 184-192.
150. Yun HS, Kim SE, Hyeon YT,. Design and preparation of bioactive glasses with hierarchical pore networks. Chem Commun 2007; 21: 2139-2141.
151. Li X, Wang X, Chen H, Jiang P, Dong X, Shi J,. Hierarchically porous bioactive glass scaffolds synthesized with a PUF and P123 co-templated approach. Chem Mater 2007; 19: 4322-4326. (Pubitemid 47340307)
152. Zhu Y, Wu C, Ramaswamy Y, Kockrick E, Simon P, Kaskel S, Zreiqat H,. Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering. Microp Mesop Mater 2008; 112: 494-503. (Pubitemid 351657477)
153. Zhu Y, Kaskel S,. Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Microp Mesop Mater 2009; 118: 176-182.
154. Wu C, Zhang Y, Zhu Y, Friis T, Xiao Y,. Structure-property relationships of silk-modified mesoporous bioglass scaffolds. Biomaterials 2010; 31: 3429-3438.
155. Dorozhkin SV,. Bioceramics of calcium orthophosphates. Biomaterials 2010; 31: 1465-1485.
156. Bergmann C, Lindner M, Zhang W, Koczur K, Kirsten A, Telle R, Fischer H,. 3D printing of bone substitute implants using calcium phosphate and bioactive glasses. J Eur Ceram Soc 2010; 30: 2563-2567.
157. Wilson J, Pigott GH, Schoen FJ, Hench LL,. Toxicology and biocompatibility of bioglasses. J Biomed Mater Res 1981; 15: 805-817. (Pubitemid 12239956)
158. Schmitt SC, Wiedemann-Al-Ahmad M, Kuschnierz J, Al-Ahmad A, Huebner U, Schmelzeisen R, Gutwald R,. Comparative in vitro study of the proliferation and growth of ovine osteoblast-like cells on various alloplastic biomaterials manufactured for augmentation and reconstruction of tissue or bone defects. J Mater Sci Mater Med 2008; 19: 1441-1450. (Pubitemid 351328131)
159. Schutte RJ, Paris-Amon A, Monty Reichert W,. Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistry. J Biomed Mater Res A 2009; 88: 128-139.
160. Mendonca G, Mendonca DBS, Simoes LGP, Araujo AL, Leite ER, Duarte WR, Aragao FJL, Cooper LF,. The effects of implant surface nanoscale features on osteoblast-specific gene expression. Biomaterials 2009; 30: 4053-4062.
161. Biggs MJP, Richards RG, Gadegaard N, Wilkinson CDW, Oreffo ROC, Dalby MJ,. The use of nanoscale topography to modulate the dynamics of adhesion formation in primary osteoblast and ERK/MAPK signalling in STRO-1+ enriched skeletal stem cells. Biomaterials 2009; 30: 5094-5013.
162. Lamers E, Walboomenrs XF, Domanski M, Te Riet J, Van Delft FCMJM, Luttge R, Winnbust LAJA, Gardeniers HJGE, Jansen JA,. The influence of nanoscale grooved substrates on osteoblast behaviour and extracellular matrix deposition. Biomaterials 2010; 31: 3307-3316.
163. Anselme K, Davidson P, Popa AM, Giazzon M, Liley M, Ploux L,. The interactions of cells and bacteria with surfaces structured at the nanometre scale. Acta Biomater 2010; 6: 3824-2846.
164. Gorustovich AA, Vargas GE, Bretcanu O, Vera Mesones E, Porto Lopez JM, Boccaccini AR,. Novel bioassay to evaluate biocompatibility of bioactive glass scaffolds for tissue engineering. Adv Appl Ceram 2008; 107: 274-276.
165. A-derived glass-ceramic scaffolds in chick embryos. Acta Biomater 2009; 5: 374-380.
166. Mourino V, Boccaccini AR,. Bone tissue engineering therapeutics: controlled drug delivery in three dimensional scaffolds. J R Soc Interf 2010; 7: 209-227.
167. Jones JR, Atwood RC, Poologasundarampillai G, Yue S, Lee PD,. Quantifying the 3D macrostructure of tissue scaffolds. J Mater Sci Mater Med 2009; 20: 463-471.
168. Scheiner S, Sinibaldi R, Pichler B, Komlev V, Renghini C, Vitale-Brovarone C, Rustichelli F, Hellmich C,. Micromechanics of bone tissue-engineering scaffolds, based on resolution error-cleared computer tomography. Biomaterials 2009; 30: 2411-2419.
169. Malasoma A, Fritsch A, Kohlhauser C, Brynk T, Vitale-Brovarone C, Pakiela Z, Eberhardsteiner J, Hellmich C,. Micromechanics of bioresorbable porous CEL2 glass ceramic scaffolds for bone tissue engineering. Adv Appl Ceram 2008; 107: 277-286.
170. Renghini C, Komlev V, Fiori F, Verné E, Baino F, Vitale-Brovarone C,. Micro-CT studies on 3-D bioactive glass-ceramic scaffolds for bone regeneration. Acta Biomater 2009; 5: 1328-1337.
171. Belicchi M, Cancedda R, Cedola A, Fiori F, Gavina M, Giuliani A, Komlev VS, Lagomarsino S, Mastrogiacomo M, Renghini C, Rustichelli F, Sykova E, Torrente Y,. Some applications of nanotechnologies in stem cells research. Mater Sci Eng B 2009; 165: 139-147.
172. A-based scaffolds for bone tissue engineering. J Biomech 2009; 42: 257-260.
173. ASTM F2027: 2008. Standard guide for characterization and testing of raw or starting biomaterials for tissue-engineered medical products.
174. ASTM F2150: 2007. Standard guide for characterization ad testing of biomaterial scaffolds used in tissue-engineered medical products.
175. ISO 10993-14: 2001. Biological evaluation of medical devices: identification and quantification of degradation products from ceramics.
176. Bohner M, Lemaitre J,. Can bioactivity be tested in vitro with SBF solution? Biomaterials 2009; 30: 2175-2179.
177. Cancedda R, Giannoni P, Mastrogiacomo M,. A tissue engineering approach to bone repair in large animal models. Biomaterials 2007; 28: 4240-4250. (Pubitemid 47212405)